National prevalence of coronary heart disease and stroke in South Africa from 1990-2017: a systematic review and meta-analysis.


Journal

Cardiovascular journal of Africa
ISSN: 1680-0745
Titre abrégé: Cardiovasc J Afr
Pays: South Africa
ID NLM: 101313864

Informations de publication

Date de publication:
Historique:
received: 16 10 2019
accepted: 02 10 2020
pubmed: 27 3 2021
medline: 29 12 2021
entrez: 26 3 2021
Statut: ppublish

Résumé

South Africa is experiencing an increasing burden of cardiovascular diseases, including coronary heart disease (CHD) and stroke. We aimed to obtain overall national prevalence estimates of CHD and stroke in South Africa. Studies conducted in South Africa were systematically reviewed from PubMed, Scopus and Web of Science from January 1990 to July 2017. Random-effects meta-analyses were conducted on the selected studies to determine the overall prevalence of CHD and stroke. Out of 2 466 studies, only 12 covering 75 140 participants reported the national prevalence of CHD and stroke. All 12 studies estimated the national prevalence of both diseases based on self-reported disease status. The overall national prevalence was 1.29 (95% CI = 0.83; 1.75) and 4.29 (95% CI = 3.13; 5.45) for CHD and stroke, respectively. Only one study reported incidence rates so we did not perform any meta-analysis of incidence rates. There are very few studies on national prevalence of CHD and stroke in South Africa. Well-structured registries for CHD and stroke are required to accurately identify the disease burden and enable adequate resources to be allocated for the implementation of appropriate prevention and management programmes.

Sections du résumé

BACKGROUND
South Africa is experiencing an increasing burden of cardiovascular diseases, including coronary heart disease (CHD) and stroke. We aimed to obtain overall national prevalence estimates of CHD and stroke in South Africa.
METHODS
Studies conducted in South Africa were systematically reviewed from PubMed, Scopus and Web of Science from January 1990 to July 2017. Random-effects meta-analyses were conducted on the selected studies to determine the overall prevalence of CHD and stroke.
RESULTS
Out of 2 466 studies, only 12 covering 75 140 participants reported the national prevalence of CHD and stroke. All 12 studies estimated the national prevalence of both diseases based on self-reported disease status. The overall national prevalence was 1.29 (95% CI = 0.83; 1.75) and 4.29 (95% CI = 3.13; 5.45) for CHD and stroke, respectively. Only one study reported incidence rates so we did not perform any meta-analysis of incidence rates.
CONCLUSIONS
There are very few studies on national prevalence of CHD and stroke in South Africa. Well-structured registries for CHD and stroke are required to accurately identify the disease burden and enable adequate resources to be allocated for the implementation of appropriate prevention and management programmes.

Identifiants

pubmed: 33769427
doi: 10.5830/CVJA-2020-045
pmc: PMC8756070
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

156-160

Références

Cardiovasc J Afr. 2015 Mar-Apr;26(2 Suppl 1):S27-38
pubmed: 25962945
Contemp Clin Trials. 2015 Nov;45(Pt A):139-45
pubmed: 26343745
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Glob Health Action. 2013 Sep 19;6:20936
pubmed: 24054088
BMC Neurol. 2015 Apr 12;15:54
pubmed: 25880843
S Afr Med J. 2009 Aug;99(8):574-5
pubmed: 19908613
Stroke. 2000 Jun;31(6):1294-8
pubmed: 10835447
J Clin Hypertens (Greenwich). 2018 Jan;20(1):47-55
pubmed: 29228472
Am J Epidemiol. 2017 Mar 15;185(6):414-428
pubmed: 28399566
Am Heart J. 2004 Aug;148(2):277-84
pubmed: 15308997
Glob Heart. 2020 Feb 12;15(1):15
pubmed: 32489788
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
BMC Health Serv Res. 2012 Sep 11;12:312
pubmed: 22967264
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Aust N Z J Public Health. 2010 Aug;34(4):394-400
pubmed: 20649780
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
S Afr Med J. 1990 Jul 21;78(2):82-5
pubmed: 2371639
Int J Stroke. 2006 Nov;1(4):180-90
pubmed: 18706015
Circulation. 2003 Nov 18;108(20):2543-9
pubmed: 14610011
Stroke. 2004 Mar;35(3):627-32
pubmed: 14963282
Lancet. 2005 Oct 29-Nov 4;366(9496):1578-82
pubmed: 16257345
Am J Prev Med. 2007 Aug;33(2):172-3
pubmed: 17673107
Ethn Dis. 2006 Autumn;16(4):872-9
pubmed: 17061740
Bull World Health Organ. 2016 Sep 1;94(9):634-634A
pubmed: 27708464
Cardiol Res Pract. 2016;2016:4364761
pubmed: 26942034
PLoS One. 2014 Jun 26;9(6):e100724
pubmed: 24967899
Diabetes Res Clin Pract. 2007 Jul;77(1):107-12
pubmed: 17141912

Auteurs

Nada Abdelatif (N)

Biostatistics Research Unit, South African Medical Research Council, Durban, South Africa. Email: nada.abdelatif@mrc.ac.za.

Nasheeta Peer (N)

Non-communicable Diseases Research Unit, South African Medical Research Council, Durban; Department of Medicine, University of Cape Town, Cape Town, South Africa.

Samuel O Manda (SO)

Biostatistics Research Unit, South African Medical Research Council, Pretoria; Department of Statistics, University of Pretoria, Pretoria; School of Mathematics, Statistics and Computer Science, University of KwaZulu-Natal, Pietermaritzburg, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH